Want to join the conversation?
$MRK 2Q15 Q&A: On the question of REMICADE biosimilar by Risinger of Morgan Stanley, Adam told there is no any major impact on products outside of REMICADE. Commenting on cancer conferences on I-O franchise, Roger told a lot of data will be available at AASLD and expect to have the opportunity to present some data with respect to triplet therapy.
Impressed with $AMZN’s latest grocery ambitions. The new Amazon Go convenience store, is an absolute game changer.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !